IBIO IBIO INC revenue, earnings and financials
For the quarter ended March 31, 2026, IBIO INC reported revenue of n/a, net income of −$7.73M and diluted EPS of −$0.06; for the fiscal year ended June 2025 revenue was $400K, up 77.8% on the year before.
IBIO annual revenue and earnings
- Fiscal year ended Jun 2025: revenue $400K, gross profit n/a, operating income −$18.6M, net income −$18.4M (margin -4595.0%), EPS −$1.75
- Fiscal year ended Jun 2024: revenue $225K, gross profit n/a, operating income −$16.6M, net income −$24.9M (margin -11071.1%), EPS −$6.50
- Fiscal year ended Jun 2023: revenue $0, gross profit n/a, operating income −$29.3M, net income −$65.0M (margin n/a), EPS −$106.19
- Fiscal year ended Jun 2022: revenue $1.88M, gross profit $2.17M, operating income −$29.7M, net income −$50.3M (margin -2670.0%), EPS −$5.78
- Fiscal year ended Jun 2021: revenue $2.37M, gross profit $909K, operating income −$31.1M, net income −$23.2M (margin -978.8%), EPS −$3.00
IBIO quarterly revenue and earnings
- Quarter ended Mar 31, 2026: revenue n/a, net income −$7.73M, EPS −$0.06
- Quarter ended Dec 31, 2025: revenue $0 (down 100.0% year over year), net income −$8.99M, EPS −$0.09
- Quarter ended Sep 30, 2025: revenue $100K, net income −$5.72M, EPS −$0.11
- Quarter ended Jun 30, 2025 (from the annual report): revenue $200K, net income −$5.17M, EPS −$0.32
- Quarter ended Mar 31, 2025: revenue $0, net income −$4.86M, EPS −$0.49
- Quarter ended Dec 31, 2024: revenue $200K, net income −$4.36M, EPS −$0.48
- Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$3.99M, EPS −$0.46
- Quarter ended Jun 30, 2024 (from the annual report): revenue n/a, net income −$7.78M, EPS $3.57
- Quarter ended Mar 31, 2024: revenue n/a, net income −$3.17M, EPS −$0.85
- Quarter ended Dec 31, 2023: revenue n/a, net income −$8.21M, EPS −$4.42
- Quarter ended Sep 30, 2023: revenue $50.0K, net income −$5.75M, EPS −$4.80
- Quarter ended Jun 30, 2023 (from the annual report): revenue $0, net income −$6.03M, EPS −$24.64
- Quarter ended Mar 31, 2023: revenue $0 (down 100.0% year over year), net income −$7.29M, EPS −$11.07
- Quarter ended Dec 31, 2022: revenue $0, net income −$33.6M, EPS −$68.43
- Quarter ended Sep 30, 2022: revenue $0 (down 100.0% year over year), net income −$18.1M, EPS −$2.05
- Quarter ended Jun 30, 2022 (from the annual report): revenue $0, net income −$17.1M, EPS −$0.59
- Quarter ended Mar 31, 2022: revenue $1.80M (up 135.3% year over year), net income −$12.4M, EPS −$1.42
- Quarter ended Dec 31, 2021: revenue $0, net income −$11.9M, EPS −$1.37
- Quarter ended Sep 30, 2021: revenue $84.0K, net income −$8.94M, EPS −$2.40
- Quarter ended Mar 31, 2021: revenue $765K, net income −$7.66M, EPS −$0.04
IBIO cash flow, buybacks and dividends
- Fiscal year ended Jun 2025: operating cash flow −$15.3M, share buybacks n/a
- Fiscal year ended Jun 2024: operating cash flow −$18.6M, share buybacks n/a
- Fiscal year ended Jun 2023: operating cash flow −$30.4M, share buybacks n/a
- Fiscal year ended Jun 2022: operating cash flow −$37.5M, share buybacks n/a
- Fiscal year ended Jun 2021: operating cash flow −$30.1M, share buybacks n/a
IBIO balance sheet
- Jun 30, 2026: cash $56.4M, total assets $99.1M, total liabilities $13.4M, shareholders' equity $85.7M
- Mar 31, 2026: cash $47.6M, total assets $85.8M, total liabilities $8.30M, shareholders' equity $77.5M
- Dec 31, 2025: cash $28.7M, total assets $64.4M, total liabilities $7.83M, shareholders' equity $56.6M
- Sep 30, 2025: cash $28.1M, total assets $64.2M, total liabilities $8.12M, shareholders' equity $56.0M
- Jun 30, 2025: cash $8.58M, total assets $23.2M, total liabilities $8.31M, shareholders' equity $14.9M
- Mar 31, 2025: cash $4.96M, total assets $19.1M, total liabilities $7.72M, shareholders' equity $11.4M
- Dec 31, 2024: cash $7.02M, total assets $21.7M, total liabilities $7.80M, shareholders' equity $13.9M
- Sep 30, 2024: cash $11.0M, total assets $24.5M, total liabilities $6.76M, shareholders' equity $17.8M
What is IBIO's revenue?
IBIO INC reported $400K of revenue for the fiscal year ended June 2025.
Is IBIO profitable?
No. IBIO INC lost $27.6M over the last four quarters.
What is IBIO's EPS?
Diluted earnings per share over the last four quarters were −$0.58; −$0.06 in the latest quarter.